Patients struggle to source 'miracle' weight loss drug
Ozempic was originally designed and is licensed for type 2 diabetes in Ireland, but its active ingredient, semaglutide, is also being widely prescribed by doctors to treat obesity.
Prime Time
• 31 May 23